Saturday 17 October 2026
Export DYN’s income statement to Excel — free account
Dyne Therapeutics, Inc.
In the quarter to June 2026, EPS fell 11.3%, free cash flow fell 39.1% and total debt rose 116.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
14.25
1.04
−6.80%
Follow DYN
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
1,110.56 | 642.27 | 123.10 | 256.01 | 376.57 | 345.31 | 14.63 | 8.12 |
Other current assets |
— | — | — | — | — | — | — | 0.03 |
Total current assets |
1,126.59 | 659.28 | 129.38 | 265.59 | 382.39 | 349.09 | 14.76 | 8.16 |
Property, Plant, Equpment (Net) |
24.03 | 5.40 | 4.78 | 5.95 | 4.68 | 1.95 | 1.49 | 0.11 |
Long-term assets (Other) |
15.60 | 1.94 | 2.32 | 2.32 | 2.31 | 2.30 | 0.19 | — |
Total non-current assets |
60.37 | 31.96 | 35.71 | 40.73 | 43.27 | 4.25 | 1.68 | — |
Total Assets |
1,186.96 | 691.23 | 165.08 | 306.33 | 425.66 | 353.33 | 16.44 | 8.27 |
Accounts Payable |
8.08 | 6.56 | 22.94 | 5.26 | 4.03 | 3.44 | 1.26 | 0.52 |
Accrued Expenses |
37.55 | 30.85 | 23.44 | 18.22 | 20.80 | 7.53 | 1.10 | — |
Other current liabilities |
— | — | — | — | — | — | — | 0.19 |
Total current liabilities |
50.63 | 42.26 | 51.10 | 28.09 | 28.72 | 10.97 | 2.36 | 0.71 |
Long Term Debt (Total) |
148.92 | — | — | 25.87 | 28.74 | — | — | 3.38 |
Non-current Liabilities (Other) |
— | — | — | — | — | — | 0.04 | 0.00 |
Total non-current liabilities |
164.20 | 19.14 | 22.70 | 25.87 | 28.74 | — | 0.04 | — |
Total liabilities |
214.83 | 61.40 | 73.79 | 53.96 | 57.47 | 10.97 | 2.40 | 4.09 |
Additional Paid In Capital |
2,367.78 | 1,579.75 | 723.80 | 649.50 | 596.93 | 421.57 | 6.35 | — |
Preferred Stock (Total) |
— | — | — | — | — | — | 27.43 | — |
Common Stock (Net) |
0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
Retained Earnings |
(1,396.14) | (949.93) | (632.51) | (396.57) | (228.47) | (79.18) | (19.75) | (4.89) |
Common Equity (Total) |
972.13 | 629.84 | 91.29 | 252.36 | 368.20 | 342.37 | (13.39) | (4.88) |
Shareholders Equity (Total) |
972.13 | 629.84 | 91.29 | 252.36 | 368.20 | 342.37 | 14.04 | 4.18 |
Shareholders Equity and Liabilities (Total) |
1,186.96 | 691.23 | 165.08 | 306.33 | 425.66 | 353.33 | 16.44 | — |
Shares (Common) |
164.95 | 102.32 | 61.47 | 55.64 | 51.57 | 45.08 | 2.59 | — |
Shareholders Equity (Tangible) |
972.13 | 629.84 | 91.29 | 252.36 | 368.20 | 342.37 | 14.04 | — |
Net Debt |
(961.64) | (642.27) | (123.10) | (230.14) | (347.83) | (345.31) | (14.63) | (4.75) |
Total Debt |
148.92 | — | — | 25.87 | 28.74 | — | — | 3.38 |
In millions of $ except per-share values · columns are period end dates